The Wall Street Journal now offers an Avian flu news tracker.
In it is a story wherein a Roche pharmaceutical exec cautions that governments need to do much more than stock up on the antiviral drug Tamiflu to fight any bird-flu pandemic, and says "mad" consumer purchases of the drug to ward off possible bird flu were making it difficult to supply patients for the normal flu season.
To that I would add some words of caution: there is not overwhelming evidence of how Tamiflu would even work against the Avian flu. And there is already at least one case reported of resistance to the drug.
Posted by schwitz at October 20, 2005 08:41 AM | TrackBack